Sonnet Biotherapeutics Receives Shareholder Approval to Merge with Hyperliquid Strategies
By: theblockbeats.news|2025/12/02 14:45:54
Condividi
BlockBeats News, December 2nd, According to market sources, Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies.
Previously reported, Hyperliquid Strategies plans to raise up to $1 billion, intended to be used to purchase HYPE, etc.
Monete popolari
Ultime notizie crypto
Assistenza clienti:@weikecs
Cooperazione aziendale:@weikecs
Trading quantitativo e MM:[email protected]
Servizi VIP:[email protected]